Ras-associated nuclear structural change appears functionally significant and independent of the mitotic signaling pathway

Journal of Cellular Biochemistry

Volumn 70, Issue 1, 1998, Pages 130-140

  Fischer, Andrew H ^a,d   Chadee, Deborah N ^b,c   Wright, Jim A ^b,c   Gansler, Ted S ^a,d   Davie, James R ^b  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d AMERICAN CANCER SOCIETY   (United States)

Author keywords

Chromatin structure; Cytology; Histones; MAPKK; Metastasis; NIH3T3 cells; Ras; Signal transduction

Indexed keywords

HISTONE;

ANIMAL CELL; ARTICLE; CELL NUCLEUS MATRIX; CHROMATIN STRUCTURE; CYTOLOGY; ENZYME ACTIVATION; FIBROBLAST; HISTOPATHOLOGY; METASTASIS POTENTIAL; MITOSIS INDEX; NONHUMAN; ONCOGENE RAS; OPEN READING FRAME; PRIORITY JOURNAL; RAT; REPRODUCIBILITY; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; CELL LINE; CELL NUCLEUS; HISTONES; MICE; MITOSIS; ONCOGENE PROTEIN P21(RAS); ONCOGENES; RATS; S PHASE; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 0032126495     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980701)70:1<130::AID-JCB13>3.0.CO;2-T     Document Type: Article

References (41)

1. Avruch J, Zhang XF, Kyriakis JM (1994): Raf meets Ras: Completing the framework of a signal transduction pathway. Trends Biochem Sci 19:279-283.
2. Barker BE, Sanford KK (1970): Cytologic manifestations of neoplastic transformation in vitro. J Natl Cancer Inst 44:39-63.
3. Berezney R, Mortillaro MJ, Ma H, Wei X, Samarabandu J (1995): The nuclear matrix: A structural milieu for genomic function. Int Rev Cytol 162A:1-65.
4. Bidwell JP, Fey EG, van Wijnen AJ, Penman S, Stein JL, Lian JB, Stein GS (1994): Nuclear matrix proteins distinguish normal diploid osteoblasts from osteosarcoma cells. Cancer Res 54:28-32.
5. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S (1991): Oncogenes and signal transduction. Cell 64:281-302.
6. Chadee DN, Taylor WR, Hurta RA, Allis CD, Wright JA, Davie JR (1995): Increased phosphorylation of histone H1 in mouse fibroblasts transformed with oncogenes or constitutively active mitogen-activated protein kinase kinase. J Biol Chem 270:20098-20105.
7. Chant J, Stowers L (1995): GTPase cascades choreographing cellular behavior: Movement, morphogenesis, and more. Cell 81:1-4.
8. Cole RD (1987): Microheterogeneity in H1 histones and its consequences. Int J Pept Protein Res 30:433-449.
9. Cotran RS, Kumar V, Robbins SL, Schoen FJ (1994): "Pathologic Basis of Disease," 5th ed. Philadelphia: WB. Saunders.
10. Cowley S, Paterson H, Kemp P, Marshall CJ (1994): Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852.
11. Davie JR (1996): Histone modifications, chromatin structure, and the nuclear matrix. J Cell Biochem 62:149-157.
12. Egan SE, Weinberg RA (1993): The pathway to signal achievement. Nature 365:781-783.
13. Egan SE, McClarty GA, Jarolim L, Wright JA, Spiro I, Hager G, Greenberg AH (1987a): Expression of H-ras correlates with metastatic potential: Evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells. Mol Cell Biol 7:830-837.
14. Egan SE, Wright JA, Jarolim L, Yanagihara K, Bassin RH, Greenberg AH (1987b): Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. Science 238:202-205.
15. Fey EG, Penman S (1984): Tumor promoters induce a specific morphological signature in the nuclear matrix-intermediate filament scaffold of Madin-Darby canine kidney (MDCK) cell colonies. Proc Natl Acad Sci U S A 81:4409-4413.
16. Fischer AH, West P, Shilkitus WW (1992): A mutated H-ras alters nuclear morphology in a rat fibroblast cell line. Patologia 25:219.
17. Frost JK (1986): "The Cell in Health and Disease: An Evaluation of Cellular Morphologic Expression of Biologic Behavior," 2nd ed. New York: Karger.
18. Haliotis T, Trimble W, Chow S, Bull S, Mills G, Girard P, Kuo JF, Hozumi N (1990): Expression of ras oncogene leads to down-regulation of protein kinase C. Int J Cancer 45:1177-1183.
19. Hanafusa H (1977): Cell transformation by RNA tumor viruses. In Fraenkel-Conrat H, Wagner RR (eds): "Comprehensive Virology." New York: Plenum Press, pp 401-483.
20. Khanuja PS, Lehr JE, Soule HD, Gehani SK, Noto AC, Choudhury S, Chen R, Pienta KJ (1993): Nuclear matrix proteins in normal and breast cancer cells. Cancer Res 53:3394-3398.
21. Laitinen J, Saris P, Holtta E (1995a): DNA methylation is not involved in the structural alterations of ornithine decarboxylase or total chromatin of c-Ha-rasVal 12 oncogene-transformed NIH-3T3 fibroblasts. J Cell Biochem 57:670-679.
22. Laitinen J, Sistonen L, Alitalo K, Holtta E (1995b): Cell transformation by c-Ha-rasVal12 oncogene is accompanied by a decrease in histone H1 degree and an increase in nucleosomal repeat length. J Cell Biochem 57:1-11.
23. Lawrence JB, Carter KC, Xing X (1993): Probing functional organization within the nucleus: Is genome structure integrated with RNA metabolism? Cold Spring Harb Symp Quant Biol 58:807-818.
24. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG (1994): Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265:966-970.
25. Mello ML, Chambers AF (1994): Image analysis of Feulgen-stained transformed NIH 3T3 cells differing in p21 expression and ras-induced metastatic ability. Anal Quant Cytol Histol 16:113-123.
26. Mello ML, Russo J (1990): Image analysis of Feulgen-stained c-H-ras-transformed NIH/3T3 cells. Biochem Cell Biol 68:1026-1031.
27. Nishio H, Nakamura S, Horai T, Ikegami H, Matsuda M (1992): Clinical and histopathologic evaluation of the expression of Ha-ras and fes oncogene products in lung cancer. Cancer 69:1130-1136.
28. Pastan I, Willingham M (1978): Cellular transformation and the 'morphologic phenotype' of transformed cells. Nature 274:645-650.
29. Perona R, Esteve P, Jimenez B, Ballestero RP, Ramon y Cajal S, Lacal JC (1993): Tumorigenic activity of rho genes from Aplysia californica. Oncogene 8:1285-1292.
30. Prendergast GC, Khosravi-Far R, Solski PA, Kurzawa H, Lebowitz PF, Der CJ (1995): Critical role of Rho in cell transformation by oncogenic Ras. Oncogene 10:2289-2296.
31. Reynolds VL, DiPietro M, Lebovitz RM, Lieberman MW (1987a): Inherent tumorigenic and metastatic properties of rat-1 and rat-2 cells. Cancer Res 47:6384-6387.
32. Reynolds VL, Lebovitz RM, Warren S, Hawley TS, Godwin AK, Lieberman MW (1987b): Regulation of a metallothionein-rasT24 fusion gene by zinc results in graded alterations in cell morphology and growth. Oncogene 1:323-330.
33. Ridley AJ, Hall A (1992): The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70:389-399.
34. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A (1992): The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70:401-410.
35. Samuel SK, Minish TM, Davie JR (1997): Altered nuclear matrix protein profiles in oncogene-transformed mouse fibroblasts exhibiting high metastatic potential. Cancer Res 57:147-151.
36. Sanford KK, Barker BE, Parshad R, Westfall BB, Woods MW, Jackson JL, King DR, Peppers EV (1970): Neoplastic conversion in vitro of mouse cells: Cytologic, chromosomal, enzymatic, glycolytic, and growth properties. J Natl Cancer Inst 45:1071-1096.
37. Santoro M, Carlomagno F, Hay ID, Herrmann MA, Grieco M, Melillo R, Pierotti MA, Bongarzone I, Della Porta G, Berger N, Peix JL, Paulin C, Fabien N, Vecchio G, Jenkins RB, Fusco A (1992): Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest 89:1517-1522.
38. Smith MR, DeGudicibus SJ, Stacey DW (1986): Requirement for c-ras proteins during viral oncogene transformation. Nature 320:540-543.
39. Taylor WR, Chadee DN, Allis CD, Wright JA, Davie JR (1995): Fibroblasts transformed by combinations of ras, myc and mutant p53 exhibit increased phosphorylation of histone H1 that is independent of metastatic potential. FEBS Lett 377:51-53.
40. Ullrich A, Schlessinger J (1990): Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212.
41. Waldman T, Lengauer C, Kinzler KW, Vogelstein B (1996): Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381:713-716.